Ceapro Inc. (CVE:CZO – Get Free Report)’s stock price dropped 11.8% during mid-day trading on Thursday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The company’s 50-day moving average price is C$0.22 and its two-hundred day moving average price is C$0.23. The company has a debt-to-equity ratio of 8.07, a current ratio of 8.54 and a quick ratio of 18.88. The company has a market capitalization of C$17.62 million, a P/E ratio of -3.75 and a beta of 1.38.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- Options Trading – Understanding Strike Price
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is the MACD Indicator and How to Use it in Your Trading
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is the Dogs of the Dow Strategy? Overview and Examples
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
